–
Immix Biopharma, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−1.35
FY22:
−8.22
FY23:
−16.1
FY24:
−22.7
FY25:
−30.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−1.35
FY22:
−8.22
FY23:
−15.6
FY24:
−22.6
FY25:
−29.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−24.4
FY22:
−8.22
FY23:
−15.6
FY24:
−21.7
FY25:
−29.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−24.4
FY22:
−8.23
FY23:
−15.4
FY24:
−21.6
FY25:
−29.4
All amounts in millions USD